Kadriu, Bashkim

Prognosis and improved outcomes in major depression: a review

Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry

Treatment of Major DepressionTranscranial Magnetic Stimulation Studies

Cited by 482

Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice

Matrisciano, F., Tueting, P., Dalal, I., Kadriu, B., Grayson, D. R., Davis, J. M., Nicoletti, F., & Guidotti, A. (2013) · Neuropharmacology

Epigenetics and DNA MethylationSchizophrenia research and treatment

Cited by 271

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

Kadriu, B., Musazzi, L., Henter, I. D., Graves, M., Popoli, M., & Zarate, C. A. (2019) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 165

Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression

Lener, M. S., Kadriu, B., & Zarate, C. A. (2017) · Drugs

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 131

Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression

Acevedo-Diaz, E. E., Cavanaugh, G. W., Greenstein, D., Kraus, C., Kadriu, B., Zarate, C. A., & Park, L. T. (2020) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 113

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals

Mkrtchian, A., Evans, J. W., Kraus, C., Yuan, P., Kadriu, B., Nugent, A. C., Roiser, J. P., & Zarate, C. A. (2021) · Molecular Psychiatry

Treatment of Major DepressionTranscranial Magnetic Stimulation Studies

Cited by 110

Ketamine in neuropsychiatric disorders: an update

Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 108

Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants

Kadriu, B., Greenwald, M., Henter, I. D., Gilbert, J. R., Kraus, C., Park, L. T., & Zarate, C. A. (2021) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionPsychedelics and Drug Studies

Cited by 99

Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

Farmer, C. A., Gilbert, J. R., Moaddel, R., George, J., Adeojo, L., Lovett, J., Nugent, A. C., Kadriu, B., Yuan, P., Gould, T. D., et al. (2020) · Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 85

The influence of ketamine on drug discovery in depression

Kraus, C., Wasserman, D., Henter, I. D., Acevedo-Diaz, E., Kadriu, B., & Zarate, C. A. (2019) · Drug Discovery Today

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 75

A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression

Park, L. T., Kadriu, B., Gould, T. D., Zanos, P., Greenstein, D., Evans, J. W., Yuan, P., Farmer, C. A., Oppenheimer, M., George, J. M., et al. (2020) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 63

Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road

Kadriu, B., Musazzi, L., Johnston, J. N., Kalynchuk, L. E., Caruncho, H. J., Popoli, M., & Zarate, C. A. (2021) · Drug Discovery Today

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 62

Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment

Kraus, C., Mkrtchian, A., Kadriu, B., Nugent, A. C., Zarate, C. A., & Evans, J. W. (2020) · Neuropsychopharmacology

Functional Brain Connectivity StudiesTreatment of Major Depression

Cited by 54

Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor

Medeiros, G. C., Greenstein, D., Kadriu, B., Yuan, P., Park, L. T., Gould, T. D., & Zarate, C. A. (2021) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 24